Immune thrombocytopenia

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
4 Unique IMPs
0 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 2
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Colony-stimulating factor 1 substance
Monoclonal antibody (human) 1 substance
Phase III: 2 Phase II: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

2 trials
  • Assistance Publique Hopitaux De Paris Academic
    BELIMUMAB
    2024-516168-27-00 1 country 2022 n=132
    Ended
  • Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla Academic
    ROMIPLOSTIM
    2024-514147-28-00 2 countries 2022 n=86
    Ended

Phase II

1 trial
  • Fakultni Nemocnice Hradec Kralove Academic
    AVATROMBOPAG; ELTROMBOPAG; ROMIPLOSTIM
    2023-505788-35-00 1 country 2025 n=50
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fakultni Nemocnice Hradec Kralove Academic 1 Phase II 1
Assistance Publique Hopitaux De Paris Academic 1 Phase III 0
Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla Academic 1 Phase III 0
New trials by year
2022
2
2025
1
← All indication landscapes